Literature DB >> 25896442

Increased hippocampal blood volume and normal blood flow in schizophrenia.

Pratik Talati1, Swati Rane2, Jack Skinner3, John Gore3, Stephan Heckers4.   

Abstract

Neuroimaging studies have provided compelling evidence for abnormal hippocampal activity in schizophrenia. Most studies made inferences about baseline hippocampal activity using a single hemodynamic parameter (e.g., blood volume or blood flow). Here we studied several hemodynamic measures in the same cohort to test the hypothesis of increased hippocampal activity in schizophrenia. We used dynamic susceptibility contrast- (DSC-) magnetic resonance imaging (MRI) to assess blood volume, blood flow, and mean transit time in the hippocampus of 15 patients with chronic schizophrenia and 15 healthy controls. Left and right hippocampal measurements were combined for absolute measures of cerebral blood volume (CBV), cerebral blood flow (CBF), and mean transit time (MTT). We found significantly increased hippocampal CBV, but normal CBF and MTT, in schizophrenia. The uncoupling of CBV and CBF could be due to several factors, including antipsychotic medication, loss of cerebral perfusion pressure, or angiogenesis. Further studies need to incorporate several complementary imaging modalities to better characterize hippocampal dysfunction in schizophrenia.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CBF; CBV; DSC-MRI; Dynamic susceptibility contrast; Gadolinium; Mean transit time

Mesh:

Year:  2015        PMID: 25896442      PMCID: PMC4439302          DOI: 10.1016/j.pscychresns.2015.03.007

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  78 in total

1.  Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia.

Authors:  Sebastian Walther; Andrea Federspiel; Helge Horn; Nadja Razavi; Roland Wiest; Thomas Dierks; Werner Strik; Thomas Jörg Müller
Journal:  Psychiatry Res       Date:  2011-04-20       Impact factor: 3.222

2.  Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.

Authors:  Carissa M White; Whitney B Pope; Taryar Zaw; Joe Qiao; Kourosh M Naeini; Albert Lai; Phioanh L Nghiemphu; J J Wang; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  J Neuroimaging       Date:  2012-06-05       Impact factor: 2.486

3.  Arterial supply to the hippocampal formation.

Authors:  Y P Huang; T Okudera
Journal:  Neuroimaging Clin N Am       Date:  1997-02       Impact factor: 2.264

4.  Anteroposterior perfusion heterogeneity in human hippocampus measured by arterial spin labeling MRI.

Authors:  Xiufeng Li; Subhendra N Sarkar; David E Purdy; Jeffrey S Spence; Robert W Haley; Richard W Briggs
Journal:  NMR Biomed       Date:  2013-02-19       Impact factor: 4.044

5.  Bolus arrival time and cerebral blood flow responses to hypercarbia.

Authors:  Manus J Donahue; Carlos C Faraco; Megan K Strother; Michael A Chappell; Swati Rane; Lindsey M Dethrage; Jeroen Hendrikse; Jeroen C W Siero
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-30       Impact factor: 6.200

6.  Relationships between cerebral perfusion pressure and regional cerebral blood flow in patients with severe neurological disorders.

Authors:  M P Heilbrun; P B Jorgensen; G Boysen
Journal:  Stroke       Date:  1972 Mar-Apr       Impact factor: 7.914

7.  Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

Authors:  C A Tamminga; G K Thaker; R Buchanan; B Kirkpatrick; L D Alphs; T N Chase; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1992-07

8.  Pseudo-continuous arterial spin labeling MRI study of schizophrenic patients.

Authors:  Miho Ota; Masanori Ishikawa; Noriko Sato; Mitsutoshi Okazaki; Norihide Maikusa; Hiroaki Hori; Kotaro Hattori; Toshiya Teraishi; Kimiteru Ito; Hiroshi Kunugi
Journal:  Schizophr Res       Date:  2014-02-26       Impact factor: 4.939

9.  Abnormalities of regional distribution of cerebral vasculature in schizophrenia detected by dynamic susceptibility contrast MRI.

Authors:  B M Cohen; D Yurgelun-Todd; C D English; P F Renshaw
Journal:  Am J Psychiatry       Date:  1995-12       Impact factor: 18.112

10.  Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging.

Authors:  Danny J J Wang; Jeffry R Alger; Joe X Qiao; Matthias Gunther; Whitney B Pope; Jeffrey L Saver; Noriko Salamon; David S Liebeskind
Journal:  Neuroimage Clin       Date:  2013-07-06       Impact factor: 4.881

View more
  22 in total

1.  Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study.

Authors:  Nina Vanessa Kraguljac; David Matthew White; Nathan Hadley; Jennifer Ann Hadley; Lawrence Ver Hoef; Ebony Davis; Adrienne Carol Lahti
Journal:  Schizophr Bull       Date:  2016-02-12       Impact factor: 9.306

2.  Hippocampal arterial cerebral blood volume in early psychosis.

Authors:  Pratik Talati; Swati Rane; Manus J Donahue; Stephan Heckers
Journal:  Psychiatry Res Neuroimaging       Date:  2016-09-09       Impact factor: 2.376

3.  Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study.

Authors:  Paulo L Lizano; Jeffrey K Yao; Neeraj Tandon; Suraj Sarvode Mothi; Debra M Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2016-11-15       Impact factor: 4.939

4.  Hippocampal Shape Abnormalities Predict Symptom Progression in Neuroleptic-Free Youth at Ultrahigh Risk for Psychosis.

Authors:  Derek J Dean; Joseph M Orr; Jessica A Bernard; Tina Gupta; Andrea Pelletier-Baldelli; Emily E Carol; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2015-06-25       Impact factor: 9.306

5.  Increased amplitude of hippocampal low frequency fluctuations in early psychosis: A two-year follow-up study.

Authors:  Maureen McHugo; Baxter P Rogers; Suzanne N Avery; Kristan Armstrong; Jennifer Urbano Blackford; Simon N Vandekar; Maxwell J Roeske; Neil D Woodward; Stephan Heckers
Journal:  Schizophr Res       Date:  2022-02-15       Impact factor: 4.939

6.  Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice.

Authors:  Daniel Scott; Carol A Tamminga
Journal:  Behav Brain Res       Date:  2017-11-15       Impact factor: 3.332

7.  Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.

Authors:  Daniel Mamah; Jie Wen; Jie Luo; Xialing Ulrich; Deanna M Barch; Dmitriy Yablonskiy
Journal:  Schizophr Res       Date:  2015-10-23       Impact factor: 4.939

8.  Preliminary Findings Associate Hippocampal 1H-MR Spectroscopic Metabolite Concentrations with Psychotic and Manic Symptoms in Patients with Schizophrenia.

Authors:  D Malaspina; E Lotan; H Rusinek; S A Perez; J Walsh-Messinger; T M Kranz; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-12       Impact factor: 3.825

9.  Anterior hippocampal dysfunction in early psychosis: a 2-year follow-up study.

Authors:  Maureen McHugo; Suzanne Avery; Kristan Armstrong; Baxter P Rogers; Simon N Vandekar; Neil D Woodward; Jennifer Urbano Blackford; Stephan Heckers
Journal:  Psychol Med       Date:  2021-04-20       Impact factor: 10.592

10.  Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome.

Authors:  Gemma Modinos; Paul Allen; Andre Zugman; Danai Dima; Matilda Azis; Carly Samson; Ilaria Bonoldi; Beverly Quinn; George W G Gifford; Sophie E Smart; Mathilde Antoniades; Matthijs G Bossong; Matthew R Broome; Jesus Perez; Oliver D Howes; James M Stone; Anthony A Grace; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.